| Literature DB >> 33868144 |
Helena Hybbinette1,2,3, Ellika Schalling1,4, Jeanette Plantin2,3, Catharina Nygren-Deboussard2,3, Marika Schütz1, Per Östberg1,4, Påvel G Lindberg2,5.
Abstract
Objective: Aphasia and apraxia of speech (AOS) after stroke frequently co-occur with a hand motor impairment but few studies have investigated stroke recovery across motor and speech-language domains. In this study, we set out to test the shared recovery hypothesis. We aimed to (1) describe the prevalence of AOS and aphasia in subacute stroke patients with a hand motor impairment and (2) to compare recovery across speech-language and hand motor domains. In addition, we also explored factors predicting recovery from AOS.Entities:
Keywords: aphasia (language); apraxia of speech; hand motor impairment; prevalence; recovery; stroke
Year: 2021 PMID: 33868144 PMCID: PMC8044583 DOI: 10.3389/fneur.2021.634065
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Participant characteristics at A1, LH lesioned (n = 35).
| Age | Mean (SD) | 53.3 (8.4)54 | 57.7 (4.7)58 | 51.0 (4.9)53 | 51.6 (9.8)53 | 0.134 | |
| Sex | N (%) | Females | 6 (17) | 2 (20) | 0 (0) | 4 (20) | |
| Males | 29 (83) | 8 (80) | 5 (100) | 16 (80) | |||
| Lesion Volume cm3 | Mean (SD) | 94.9 (102.8)45.5 | 49.4 (104.3) 4.7 | 88.6 (111.6) 25.6 | 120.9 (96.8) | 0.051 | |
| Stroke type | N (%) | Ischemic | 24 (69) | 7 (70) | 4 (80) | 13 (65) | |
| Hemorrhage | 11 (31) | 3 (30) | 1 (20) | 7 (35) | |||
| FM-UE total (60p) | Mean (SD) | 25.1 (24.9)16 | 39.7 (22.3) 51.5 | 37.6 (27.0) 57.0 | 14.7 (21.5)2.0 | 0.020 | |
SLI, speech-language impairment, Aphasia diagnoses according to A-NING test score, AOS diagnoses according to ASRS, Percent is calculated as proportion within the respective group.
Kruskal Wallis Test,
Significant at p < 0.05, Bonferroni corrected pairwise comparison.
AOS + Aphasia compared no SLI p = 0.04, Aphasia only compared to AOS + Aphasia p = 0.17, Aphasia only compared to no SLI p = 1.0.
Participant characteristics and lesion descriptives (n = 15).
| 1 | F | 52 | I | 30.6 | MCA, C and SC |
| 2 | M | 65 | I | 121.9 | MCA, C and SC |
| 3 | M | 57 | I | 32.9 | MCA, C and SC |
| 4 | F | 39 | I | 117.1 | MCA, C and SC |
| 5 | M | 31 | H | 167.7 | MCA, C and SC |
| 6 | M | 50 | I | 115.1 | MCA, C and SC |
| 7 | M | 45 | H | 143.2 | MCA, C and SC |
| 8 | M | 39 | I | 175.6 | MCA, C and SC |
| 9 | F | 62 | I | MCA, SC | |
| 10 | M | 53 | I | 270.2 | MCA, C and SC |
| 11 | M | 61 | I | 160.2 | MCA, C and SC |
| 12 | M | 44 | I | 122.7 | MCA, C and SC |
| 13 | M | 54 | H | 25.6 | MCA, C and SC |
| 14 | M | 54 | I | 73.1 | MCA, C and SC |
| 15 | M | 48 | I | 317.8 | MCA, C and SC |
| Mean(SD) | 50.3 (9.4) | 133.8 (84.7) | |||
| Median | 52 | 122.3 |
F, female; M, male; I, ischemic stroke; H, hemorrhagic stroke; MCA, middle cerebral artery; C, cortical; SC, subcortical.
Data missing.
Figure 1Lesion overlap map (n = 14) (1 missing data). All lesions were in LH MCA territory. Lesion overlap was greatest in subcortical white matter in striatocapsular region.
Behavioral measurements, total score results, assessment 1 (A1) and 2 (A2) (n = 15).
| 1 | 44 | 35 | 35 | 95 | 0 | 4 | 0 | 21 | 16 | 17 | |
| 2 | 18 | 15 | 36 | 46 | 0 | 2 | 1 | 2 | 6 | 7 | |
| 3 | 23 | 15 | 26 | 86 | 1 | 9 | 0 | 5 | 2 | 9 | |
| 4 | 22 | 14 | 70 | 120 | 2 | 10 | 12 | 38 | 17 | 20 | |
| 5 | 17 | 9 | 134 | 202 | 2 | 29 | 49 | 51 | 18 | 30 | |
| 6 | 17 | 5 | 160 | 200 | 1 | 7 | 15 | 48 | 21 | 32 | |
| 7 | 29 | 28 | 22 | 25 | 0 | 2 | 0 | 0 | 0 | 2 | |
| 8 | 28 | 18 | 38 | 173 | 16 | 34 | 0 | 44 | 5 | 21 | |
| 9 | 10 | 2 | 207 | 216 | 2 | 23 | 45 | 50 | 27 | 32 | |
| 10 | 6 | 2 | 199 | 218 | 57 | 60 | 57 | 57 | 29 | 32 | |
| 11 | 9 | 2 | 150 | 190 | 21 | 51 | 17 | 43 | 12 | 20 | |
| 12 | 7 | 7 | 118 | 192 | 7 | 40 | 32 | 42 | 26 | 27 | |
| 13 | 7 | 3 | 181 | 206 | 57 | 60 | 52 | 52 | 23 | 32 | |
| 14 | 32 | 23 | 18 | 133 | 58 | 60 | 0 | 49 | 26 | 30 | |
| 15 | 25 | 24 | 10 | 25 | 0 | 4 | 0 | 0 | 0 | 0 | |
| Mean | 19.6 | 13.5 | 93.6 | 141.8 | 14.9 | 26.3 | 18.7 | 33.5 | 15.2 | 20.7 | |
| (SD) | 10.9 | 10.5 | 72.8 | 71.0 | 22.8 | 23.0 | 22.1 | 21.4 | 10.4 | 11.5 | |
| Median | 18 | 14 | 70 | 173 | 2 | 23 | 12 | 43 | 17 | 21 | |
ASRS, Apraxia of speech rating scale, max 52, cut-off value for AOS ≥ 8 points; A-NING, A-ning neurolinguistic aphasia examination, total score results and severity index classification: very severe/Global ≤ 42 (INDEX ≤ 0.9), Severe ≤ 82 (INDEX ≤ 1.8), Moderate ≤ 170 (INDEX ≤ 3,8), Moderate/mild ≤ 192 (INDEX ≤ 4.4), Mild ≤ 208 (INDEX ≤ 4.7), No Aphasia > 208 (INDEX > 4.8), maximum 220 points; FM-UE, upper extremity motor portion of the Fugl-Meyer scale, max 60, cut-off level severe—moderate imp. 19 ± 2 points, moderate—mild 47 ± 2 points; BNT, Boston naming test, max 60, cut-off value ≤ 47–55 based on normative data (education); NVOA, non verbal oral apraxia protocol, max 32, cut-off value for NVOA diagnosis < 29 points.
Correlation between assessments at A1 and A2 (n = 15).
| ASRS vs. | A-NING | −0.83 | <0.001 |
| FM-UE | −0.46 | 0.08 | |
| NVOA | −0.58 | 0.02 | |
| BNT | −0.92 | <0.001 | |
| Lesion volume | −0.18 | 0.55 | |
| FM-UE vs. | A-NING | 0.45 | 0.10 |
| NVOA | 0.64 | 0.01 | |
| BNT | 0.48 | 0.07 | |
| Lesion volume | −0.01 | 0.96 | |
| A-NING vs. | BNT | 0.89 | <0.001 |
| NVOA | 0.68 | 0.005 | |
| Lesion volume | 0.02 | 0.95 | |
| NVOA vs. | BNT | 0.72 | 0.003 |
| Lesion volume | −0.21 | 0.48 | |
| BNT vs. | Lesion volume | 0.11 | 0.71 |
| ASRS vs. | A-NING | −0.83 | <0.001 |
| FM-UE | −0.57 | 0.03 | |
| NVOA | −0.71 | 0.003 | |
| BNT | −0.68 | 0.005 | |
| Lesion volume | −0.09 | 0.76 | |
| FM-UE vs. | A-NING | 0.71 | 0.003 |
| NVOA | 0.69 | 0.004 | |
| BNT | 0.80 | <0.001 | |
| Lesion volume | −0.01 | 0.97 | |
| A-NING vs. | BNT | 0.94 | <0.001 |
| NVOA | 0.94 | <0.001 | |
| Lesion volume | 0.01 | 0.98 | |
| NVOA vs. | BNT | 0.94 | <0.001 |
| Lesion volume | −0.16 | 0.59 | |
| BNT vs. | Lesion volume | −0.04 | 0.90 |
Significant at p < 0.05,
Significant at p < 0.01.
Descriptive statistics, recovery ratios.
| Mean (SD) | 48 (29.4) | 38 (26.3) | 38 (30.5) | 45 (39.3) | 26 (25.2) |
| Median | 57 | 35 | 35 | 31 | 14 |
| Min. | 1 | 4 | 0 | 0 | 3 |
| Max. | 90 | 80 | 82 | 100 | 77 |
Total score results at ceiling at A1 excluded in the analyses; A-NING > 200; ASRS < 9; BNT 2 points below the normative value, NVOA ≥ 28; FM-UE ≥ 57.
Figure 2Relation recovery ratios. (A) AOS recovery ratio (ASRS) correlated with recovery ratio of aphasia (A-NING) (Rho = 0.80, p < 0.01). (B) AOS recovery ratio (ASRS) correlated with recovery ratio of hand motor impairment (FM-UE) (Rho = 0.78, p < 0.01). (C) Aphasia recovery (A-NING) correlated with recovery of hand motor impairment (FM-UE) (Rho = 0.80, p < 0.01).
Relation between recovery ratios.
| ASRS vs. | A-NING | 0.80 | 0.003 |
| FM-UE | 0.78 | 0.004 | |
| NVOA | 0.84 | 0.001 | |
| BNT | 0.55 | 0.055 | |
| Lesion volume | −0.005 | 0.989 | |
| FM-UE vs. | A-NING | 0.80 | 0.003 |
| NVOA | 0.59 | 0.045 | |
| BNT | 0.65 | 0.029 | |
| Lesion volume | 0.25 | 0.464 | |
| A-NING vs. | BNT | 0.84 | 0.001 |
| NVOA | 0.74 | 0.004 | |
| Lesion volume | 0.25 | 0.391 | |
| NVOA vs. | BNT | 0.72 | 0.008 |
| Lesion volume | −0.28 | 0.357 | |
| BNT vs. | Lesion volume | −0.20 | 0.563 |
Significant at p < 0.05,
Significant at p < 0.01.
Univariate linear regression analyses (n = 15).
| ASRS recovery ratio | A-NING total at A1 | 0.836 | <0.0001 |
| ASRS total at A1 | 0.525 | 0.008 | |
| BNT total at A1 | 0.448 | 0.017 | |
| NVOA total score at A1 | 0.353 | 0.04 | |
| Age | 0.047 | 0.497 | |
| FM-UE at A1 | 0.006 | 0.818 | |
| Lesion volume cm3 | 0.001 | 0.942 |
Significant at p < 0.05,
Significant at p < 0.01.
Figure 3Total score changes between A1 and A2 in ASRS, FM-UE, and A-NING. In ASRS, higher scores reflect greater severity.
Figure 4Recovery ratios in participants with severe initial aphasia (n = 7). *Blue striped plot shows FM-UE result at ceiling at A1.
Relation recovery ratios in the group with severe aphasia (n = 7).
| ASRS vs. | A-NING | 0.79 | 0.04 |
| FM-UE | 0.74 | 0.09 | |
| NVOA | 0.83 | 0.02 | |
| BNT | 0.81 | 0.03 | |
| Lesion vol. cm3 | −0.36 | 0.43 | |
| FM-UE vs. | A-NING | 0.88 | 0.02 |
| NVOA | 0.69 | 0.13 | |
| BNT | 0.72 | 0.11 | |
| Lesion vol. cm3 | 0.09 | 0.87 | |
| A-NING vs. | BNT | 0.90 | 0.006 |
| NVOA | 0.72 | 0.07 | |
| Lesion vol. cm3 | −0.18 | 0.70 | |
| NVOA vs. | BNT | 0.84 | 0.02 |
| Lesion vol. cm3 | −0.32 | 0.48 | |
| BNT vs. | Lesion vol. cm3 | −0.43 | 0.33 |
Significant at p < 0.05,
Significant at p < 0.01.